In the past, the life expectancy of men with metastaticprostate cancerwas 2-3 years. Butwith advancements in medicine and care, the life expectancy of men with metastatic prostatecancerhas increased to about 5-6 years. The 5-year survival rate of metastatic prostate canceris 28%, which is m...
CancerDanzig M. R., McKiernan J. M. (2014). Overtreatment of men with early-stage prostate cancer and limited life expectancy . Cancer 120 , 3592–3594. 10.1002/cncr.28927 [ Cross Ref ]Matthew R., DanzigJames M., McKiernan. (2014) Overtreatment of men with early-stage prostate cancer...
Donohue, J. P., Thornhill, J. A., Foster, R. S., Rowland, R. G. & Bihrle, R. Clinical stage B non-seminomatous germ cell testis cancer: the Indiana University experience (1965–1989) using routine primary retroperitoneal lymph node dissection.Eur. J. Cancer31A, 1599–1604 (1995). ...
3B). In addition, the intensity of cathepsin Z staining was positively correlated with bile duct loss in PBC (r = 0.51, P = 0.01) (Fig. 3B). By contrast, the intensity of cathepsin Z staining was not increased with progression of CHC (Fig. 3Ag,h). Figure 3 ...
The prognosis and prediction of adjuvant chemotherapy (ACT) response in early-stage non-small cell lung cancer (NSCLC) patients remain poor in this era of personalized medicine. We hypothesize that extracellular matrix (ECM)-associated components could b
Prostate cancer remains a challenge due to its incidence and radical prostatectomy continues to be a major treatment option for men with potentially curable disease who have a life expectancy over a decade. This article will address the common problem of positive surgical margins and the impact of...
Prostate cancer remains a challenge due to its incidence and radical prostatectomy continues to be a major treatment option for men with potentially curable disease who have a life expectancy over a decade. This article will address the common problem of positive surgical margins and the impact of...
PD13-03OVERTREATMENT OF MEN WITH LIMITED LIFE EXPECTANCY FOR EARLY STAGE PROSTATE CANCER HAS INCREASED IN THE ACTIVE SURVEILLANCE ERAdoi:10.1097/01.JU.0001009552.62973.71.03Timothy J. DaskivichJohn HeardI-Chun ThomoasJohn LeppertWolters KluwerThe Journal of Urology...
Triple-negative breast cancer is a life-threatening disease, even when identified at early stages. Recent advances have allowed the improvement of life expectancy via a personalized approach with the addition of newer chemotherapies, immunotherapies, and targeted therapies, but at the cost of added ...
Follicular lymphoma (FL) is a common mature B-cell malignancy, characterised by a long natural history, remarkable sensitivity to radiation therapy (RT) [1] and high response rates to immunochemotherapy [2]. Grade 3B follicular lymphoma is biologically akin to the aggressive diffuse large B-cell...